,,ib ,union ,cal5d> ,no4 #cd #aah? ,,congress #a/ ,session ,h4 ,r4 #agcd ,report ,no4 #aah-ej ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,m>* #bc1 #bjbc,mr4 ,coll9s 7= himself1 ,ms4 ,c>aveo1 ,mr4 ,lucas1 ,ms4 ,l(gr51 ,mr4 ,craw=d1 ,mrs4 ,f\%ee1 ,mr4 ,ob]nolte1 ,mrs4 ,mc,clellan1 ,mr4 ,kean ( ,new ,j]sey1 ,ms4 ,ross1 ,mr4 ,mike ,g>cia ( ,cali=nia1 ,mr4 ,mull91 ,ms4 ,t5ney1 ,mr4 ,sor5s51 ,mr4 ,williams ( ,new ,york1 ,mr4 ,trone1 ,mr4 ,web] ( ,texas1 ,mr4 ,bab91 & ,mr4 ,/rong7 introduc$ ! foll[+ bill2 :i* 0 ref]r$ to ! ,committee on ,sci5ce1 ,space1 & ,te*nology ,may #e1 #bjbc;,additional sponsors3 ,mr4 ,c4 ,scott ,frankl9 ( ,florida1 ,mr4 ,mill] ( ,ohio1 ,mr4 ,jackson ( ,nor? ,c>ol9a1 ,ms4 ,/ev5s1 ,mrs4 ,sykes1 ,ms4 ,lee ( ,p5nsylvania1 & ,mr4 ,pappas ,may #e1 #bjbc,report$ ) an am5dm5t1 committ$ to ! ,committee ( ! ,:ole ,h\se on ! ,/ate ( ! ,union1 & ord]$ to be pr9t$ ,a ,,bill ,to require coord9at$ ,national ,in/itute ( ,/&>ds & ,te*nology sci5ce & rese>* activities reg>d+ illicit drugs conta9+ xylaz9e1 novel syn!tic opioids1 & o!r sub/ances ( conc]n1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,te/+1 ,rapid ,analysis1 & ,n>cotic ,quality ,rese>* ,act or ! ,,tranq ,rese>* ,act4 #b4 ,xylaz9e detection & analysis 7a7 ,9 g5]al ,! ,director %all-- 7#a7 support ,,ni/ intramural basic measurem5t sci5ce & rese>* to advance-- 7,a7 analytical me?ods to id5tify1 und]/&1 diff]5tiate1 & categorize illicit drugs conta9+ xylaz9e1 novel syn!tic opioids1 or o!r em]g+ sub/ances ( conc]n2 7,b7 measurem5t te*nologies to %ort5 analysis timel9es & enhance n>cotic & opioid detection & analysis capabilities 9 illicit drugs2 7,c7 new data tools1 te*niques1 & processes to id5tify & publicly disclose relevant in=mation conc]n+ illicit drugs conta9+ xylaz9e1 novel syn!tic opioids1 or o!r em]g+ sub/ances ( conc]n2 & 7,d7 all o!r areas det]m9$ by ! ,director to be critical to ! developm5t & deploym5t ( te*nologies to measure & analyze ! pres5ce ( xylaz9e1 novel syn!tic opioids1 & o!r em]g+ sub/ances ( conc]n 9 illicit drugs2 7#b7 support activities to in=m & exp& ! developm5t ( ne>-real "t spectrometry capabilities reg>d+ xylaz9e1 novel syn!tic opioids1 & o!r em]g+ comp\nds 9 illicit drugs2 7#c7 conv5e ! private sector1 in/itutions ( high] education1 nonpr(it organizations1 ,f$]al laboratories1 & o!r ,f$]al ag5cies engag$ 9 ! analysis ( illicit drugs to develop coord9at$ /rategies & volunt>y be/ practices = ! safe h&l+1 transport1 & analysis ( illicit drugs conta9+ xylaz9e1 novel syn!tic opioids1 or o!r em]g+ sub/ances ( conc]n2 7#d7 e/abli% or exp& collaborative p>tn]%ips or consortia ) o!r gov]nm5t ag5cies engag$ 9 c\nt]n>cotic rese>* & developm5t1 in/itutions ( high] education1 ,f$]al laboratories1 & ! private sector to enhance n>cotic & opioid detection & analysis capabilities reg>d+ xylaz9e1 novel syn!tic opioids1 & o!r em]g+ sub/ances ( conc]n 9 illicit drugs2 & 7#e7 provide opportunities = graduate & po/graduate rese>* on ! detection & id5tification ( xylaz9e1 novel syn!tic opioids1 & o!r em]g+ sub/ances ( conc]n 9 illicit drugs4 7b7 ,controls ,9 c>ry+ out activities au?oriz$ "u ?is section1 ! ,director %all ensure prop] security controls are implem5t$ to protect s5sitive in=mation1 z appropriate4 7c7 ,def9itions ,9 ?is section3 7#a7 ,director ,! t]m ,director means ! ,director ( ! ,national ,in/itute ( ,/&>ds & ,te*nology4 7#b7 ,f$]al laboratory ,! t]m ,f$]al laboratory has ! mean+ giv5 su* t]m 9 section #d ( ! ,/ev5son-,wydl] ,te*nology ,innovation ,act ( #aihj 7#ae ,u4,s4,c4 #cgjc74 7#c7 ,in/itution ( high] education ,! t]m in/itution ( high] education has ! mean+ giv5 su* t]m 9 section #aja ( ! ,high] ,education ,act ( #aife 7#ai ,u4,s4,c4 #ajja74 7#d7 ,,ni/ ,! t]m ,,ni/ means ! ,national ,in/itute ( ,/&>ds & ,te*nology4 7#e7 ,nonpr(it organization ,! t]m nonpr(it organization means an organization describ$ 9 section #eja7;c77#c7 ( ! ,int]nal ,rev5ue ,code ( #aihf & exempt f tax "u section #eja7;a7 ( su* code4 7#f7 ,xylaz9e ,! t]m xylaz9e means ! nonopioid tranquiliz] me?yl b5z5e comp\nd frequ5tly us$ 9 vet]9>y m$ic9e z an emetic & s$ative ) analgesic & muscle relaxant prop]ties4 #c4 ,report ,n lat] t #a ye> aft] ! date ( enactm5t ( ?is ,act1 ! ,director ( ! ,national ,in/itute ( ,/&>ds & ,te*nology %all submit to ! ,committee on ,sci5ce1 ,space1 & ,te*nology ( ! ,h\se ( ,repres5tatives & ! ,committee on ,comm]ce1 ,sci5ce1 & ,transportation ( ! ,s5ate a report on ! implem5tation ( ?is ,act4 ,su* report may include legislative recomm5dations to improve ! ,director's ability to c>ry out section #b4 ,may #e1 #bjbc,report$ ) an am5dm5t1 committ$ to ! ,committee ( ! ,:ole ,h\se on ! ,/ate ( ! ,union1 & ord]$ to be pr9t$